For research use only
| Cat No. | ABC-TC3866 |
| Product Type | Cardiac Cells |
| Cell Type | Interstitial Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Valvular Interstitial Cells from heart valves express smooth muscle actin and support valve biology, fibrosis, and calcification studies.
Human Valvular Interstitial Cells (hVICs) are primary fibroblast-like cells isolated from normal human aortic valve tissue. These cells exhibit fibroblast-like morphology with elongated, spindle-shaped profiles under standard culture conditions. Functionally, hVICs participate in valvular homeostasis, but under pathological stimuli, they contribute to calcific aortic valve disease (CAVD) through osteogenic differentiation, a process marked by upregulated alkaline phosphatase (ALP) and collagen type I expression. Inflammatory pathways such as NLRP3 inflammasome activation and TGF-β signaling, further exacerbate extracellular matrix (ECM) stiffening and calcium deposition, both hallmarks of CAVD progression. Immunophenotyping confirms their identity through positive staining for vimentin and α-SMA, while remaining negative for endothelial markers such as Factor VIII. hVICs require careful handling, repeated freeze-thaw cycles should be avoided to maintain optimal viability.
| Species | Human |
| Cat.No | ABC-TC3866 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Interstitial Cell |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Cardiac Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Valvular Interstitial Cells (hVICs) are extensively used as an in vitro model to investigate the pathogenesis of calcific aortic valve disease (CAVD). Their responsiveness to pathological cues, including hyperlipidemia, inflammation, and mechanical stress, makes them ideal for studying osteogenic transdifferentiation, extracellular matrix (ECM) remodeling, and mechanotransduction. These cells are widely utilized in preclinical screening of potential therapeutic candidates aimed at halting or reversing valve calcification. Their ability to recapitulate disease-associated phenotypes, such as calcific nodule formation and α-SMA expression, makes them valuable for studying early-stage valve degeneration and potential intervention points.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
These cells are derived from the heart valve tissue of healthy human donors or patients undergoing surgery.
Yes, these cells are commonly used for studying valve-related diseases, fibrosis, and calcification.
These cells should be cultured in a fibroblast-specific medium with growth supplements to maintain viability.
Yes, they are suitable for preclinical drug testing aimed at treating or preventing valvular diseases.